Vaccination News

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The American Academy of Dermatology has created a measles resource center for dermatologists to stay prepared during the current U.S. measles outbreak.

SAN FRANCISCO — A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk for long COVID, according to study data.

SAN FRANCISCO — Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic Infections.

Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective antibodies that persisted for up to a year after vaccination with no significant safety events, researchers found.

An adult in New Mexico tested positive for measles after dying, state health officials announced Thursday amid a growing outbreak of the highly contagious disease centered in neighboring Texas.

Lawmakers grilled Martin Makary, MD, MPH, on transparency, his plans for mifepristone and his stance on the recently cancelled Vaccine Advisory Committee meeting during Thursday’s senate hearing to be the next FDA commissioner.

Senators questioned Jay Bhattacharya, MD, PhD, about proposed NIH cuts to biomedical research, the safety of vaccines, and government transparency during his nomination hearing Wednesday to be the next director of the NIH.

HPV is the most common sexually transmitted infection, yet many people lack knowledge of the infection or hold several misconceptions about it.